A new classification of cardio-oncology syndromes.

Cancer Cardiac Tumours Cardio-oncology Cardiotoxicity Cardiovascular disease Heart failure Immune system Inflammation Medical diagnostic radiation Prevention Prognostic biomarkers

Journal

Cardio-oncology (London, England)
ISSN: 2057-3804
Titre abrégé: Cardiooncology
Pays: England
ID NLM: 101689938

Informations de publication

Date de publication:
21 Jun 2021
Historique:
received: 11 02 2021
accepted: 30 05 2021
entrez: 22 6 2021
pubmed: 23 6 2021
medline: 23 6 2021
Statut: epublish

Résumé

Increasing evidence suggests a multifaceted relationship exists between cancer and cardiovascular disease (CVD). Here, we introduce a 5-tier classification system to categorize cardio-oncology syndromes (COS) that represent the aspects of the relationship between cancer and CVD. COS Type I is characterized by mechanisms whereby the abrupt onset or progression of cancer can lead to cardiovascular dysfunction. COS Type II includes the mechanisms by which cancer therapies can result in acute or chronic CVD. COS Type III is characterized by the pro-oncogenic environment created by the release of cardiokines and high oxidative stress in patients with cardiovascular dysfunction. COS Type IV is comprised of CVD therapies and diagnostic procedures which have been associated with promoting or unmasking cancer. COS Type V is characterized by factors causing systemic and genetic predisposition to both CVD and cancer. The development of this framework may allow for an increased facilitation of cancer care while optimizing cardiovascular health through focused treatment targeting the COS type.

Identifiants

pubmed: 34154667
doi: 10.1186/s40959-021-00110-1
pii: 10.1186/s40959-021-00110-1
pmc: PMC8218489
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

24

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : H2020 European Research Council
ID : 818715

Références

J Med Genet. 2014 Oct;51(10):669-76
pubmed: 25157032
Onco Targets Ther. 2018 Sep 25;11:6227-6237
pubmed: 30288058
Oncol Rep. 2017 May;37(5):2543-2552
pubmed: 28393216
Circulation. 2018 Aug 14;138(7):678-691
pubmed: 29459363
Cardiovasc Res. 2019 Apr 15;115(5):844-853
pubmed: 30715247
J Am Coll Cardiol. 2018 Apr 24;71(16):1755-1764
pubmed: 29567210
Cancer Res. 2011 Mar 1;71(5):1710-20
pubmed: 21163868
Biophys J. 1995 Mar;68(3):1027-44
pubmed: 7756523
Am J Med. 2018 Sep;131(9):1095-1103
pubmed: 29807000
Cancer Manag Res. 2019 Oct 30;11:9265-9276
pubmed: 31802946
J Cardiovasc Transl Res. 2020 Jun;13(3):402-416
pubmed: 32253744
Sci Transl Med. 2014 Feb 19;6(224):224ra25
pubmed: 24553386
J Thromb Haemost. 2003 Oct;1(10):2097-102
pubmed: 14521590
Thromb Haemost. 2016 Jan;115(2):415-23
pubmed: 26446551
J Am Coll Cardiol. 2008 Nov 4;52(19):1527-39
pubmed: 19007588
Eur Heart J. 2020 Feb 07;:
pubmed: 32030399
PLoS One. 2012;7(3):e33411
pubmed: 22448244
Heart. 2017 Mar;103(5):341-346
pubmed: 27540181
Circulation. 2020 Aug 18;142(7):684-687
pubmed: 32804565
BMJ. 2015 Aug 18;351:h4238
pubmed: 26286216
N Engl J Med. 2014 Oct 16;371(16):1507-17
pubmed: 25317870
J Am Coll Cardiol. 2019 Dec 24;74(25):3099-3108
pubmed: 31856966
Cancer J. 2014 Mar-Apr;20(2):119-22
pubmed: 24667956
Nat Med. 2018 Jun;24(6):731-738
pubmed: 29808005
Int J Mol Sci. 2019 May 06;20(9):
pubmed: 31064116
Sci Rep. 2019 Jun 12;9(1):8565
pubmed: 31189941
J Am Coll Cardiol. 2019 Sep 24;74(12):1594-1607
pubmed: 31537270
Circulation. 2020 Aug 18;142(7):670-683
pubmed: 32475164
Nat Rev Cancer. 2007 Aug;7(8):599-612
pubmed: 17646865
Nat Rev Cancer. 2008 Mar;8(3):205-11
pubmed: 18235448
Oncologist. 2018 Aug;23(8):943-947
pubmed: 29622697
BMJ. 2018 Oct 24;363:k4209
pubmed: 30355745
Circulation. 1999 Sep 7;100(10):1132-3
pubmed: 10477541
J Am Coll Cardiol. 2019 Jul 30;74(4):567-577
pubmed: 31345432
Eur J Heart Fail. 2016 Mar;18(3):260-6
pubmed: 26751260
Circulation. 2016 Mar 15;133(11):1104-14
pubmed: 26976915
Atherosclerosis. 2016 Sep;252:32-39
pubmed: 27494449
Br J Sports Med. 2016 Mar;50(6):339-45
pubmed: 26385207
Eur J Heart Fail. 2020 Dec;22(12):2272-2289
pubmed: 33094495
J Immunother Cancer. 2018 Jun 15;6(1):56
pubmed: 29907163
Immunol Res. 2000;21(2-3):279-88
pubmed: 10852128
PLoS One. 2009;4(3):e4812
pubmed: 19277124
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Am J Hum Genet. 2017 Jul 6;101(1):50-64
pubmed: 28669404
JAMA. 2007 Dec 12;298(22):2634-43
pubmed: 18073359
JAMA Cardiol. 2016 Jul 1;1(4):389-96
pubmed: 27438314
Lancet Oncol. 2007 Apr;8(4):292-3
pubmed: 17431955
J Natl Cancer Inst. 2011 Oct 5;103(19):1461-8
pubmed: 21813413
JAMA Oncol. 2018 Mar 8;4(3):e174519
pubmed: 29285538
Ann Intern Med. 2015 Jan 20;162(2):123-32
pubmed: 25599350
N Engl J Med. 1998 Apr 23;338(17):1169-73
pubmed: 9554856
Heart Views. 2015 Jul-Sep;16(3):88-92
pubmed: 27326349
J Am Heart Assoc. 2020 Nov 17;9(22):e016836
pubmed: 33140676
Curr Oncol Rep. 2020 Jun 9;22(7):67
pubmed: 32514994
Circulation. 2016 Feb 2;133(5):537-41
pubmed: 26831435
Int J Cardiol. 2020 Jun 1;308:54-59
pubmed: 32209267
Am J Med. 2017 Jul;130(7):780-785
pubmed: 28344133
Circulation. 2013 Nov 12;128(20):2192-201
pubmed: 24016454
JAMA. 2005 May 25;293(20):2479-86
pubmed: 15914748
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-S54
pubmed: 19555858
J Am Coll Cardiol. 2015 Sep 22;66(12):1378-91
pubmed: 26383726
Clin Med Insights Cardiol. 2019 Jul 29;13:1179546819866445
pubmed: 31384135
J Hypertens. 2011 Apr;29(4):623-35
pubmed: 21358417
J Am Coll Cardiol. 2018 Jul 10;72(2):202-227
pubmed: 29976295
Int J Cardiol. 2018 Jan 1;250:58-59
pubmed: 29169761
Sci Rep. 2017 Mar 20;7:44877
pubmed: 28317900
Circulation. 2018 Feb 20;137(8):e30-e66
pubmed: 29437116
J Am Coll Cardiol. 2017 Nov 14;70(20):2552-2565
pubmed: 29145955
Circulation. 2013 Feb 26;127(8):938-44
pubmed: 23439446
J Am Heart Assoc. 2017 Jan 20;6(1):
pubmed: 28108465
J Am Coll Cardiol. 2016 Jul 19;68(3):265-271
pubmed: 27417004
Lancet. 1998 Apr 11;351(9109):1077-80
pubmed: 9660575
Am J Physiol. 1997 Jul;273(1 Pt 1):C239-45
pubmed: 9252462
Biol Blood Marrow Transplant. 2016 Oct;22(10):1851-1860
pubmed: 27318038
Maturitas. 2016 Sep;91:135-9
pubmed: 27451331
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
Circulation. 2016 Mar 29;133(13):1272-89
pubmed: 27022039
Sci Transl Med. 2018 Nov 14;10(467):
pubmed: 30429355
Science. 2013 Nov 29;342(6162):1094-8
pubmed: 24288332
JCI Insight. 2019 May 16;4(10):
pubmed: 31092729
J Am Coll Cardiol. 2020 Mar 3;75(8):901-915
pubmed: 32130926
Cerebrovasc Dis. 2015;39(5-6):262-8
pubmed: 25871304
Front Cardiovasc Med. 2020 Jan 10;6:187
pubmed: 31998754
Nat Rev Dis Primers. 2018 Jan 18;4:17105
pubmed: 29345251
N Engl J Med. 2000 Jun 29;342(26):1953-8
pubmed: 10874063
J Cardiol. 2018 Aug;72(2):89-93
pubmed: 29588087
JAMA Cardiol. 2019 Jan 1;4(1):25-33
pubmed: 30566180
Circulation. 2011 Apr 26;123(16):1729-36
pubmed: 21482967
Blood. 2017 Sep 28;130(13):1499-1506
pubmed: 28807983
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):287-302
pubmed: 26675762
J Am Coll Cardiol. 2017 Aug 22;70(8):926-938
pubmed: 28818202
N Engl J Med. 2017 Jul 13;377(2):111-121
pubmed: 28636844
J Intern Med. 2020 Aug;288(2):207-218
pubmed: 32372544
Clin Pharmacol Ther. 2017 Jan;101(1):65-80
pubmed: 27806435
Curr Hematol Malig Rep. 2020 Apr;15(2):130-132
pubmed: 32016789
J Am Coll Cardiol. 2013 Sep 3;62(10):881-6
pubmed: 23810869
Lancet. 2012 Aug 4;380(9840):499-505
pubmed: 22681860
Oncogene. 2016 Nov 17;35(46):5931-5941
pubmed: 27086930
J Am Coll Cardiol. 2017 Oct 31;70(18):2278-2289
pubmed: 29073957
Arch Intern Med. 2006 Dec 11-25;166(22):2437-45
pubmed: 17159008
Jpn Heart J. 2004 Mar;45(2):183-93
pubmed: 15090695
Transfus Med Hemother. 2013 Oct;40(5):336-43
pubmed: 24273487
J Am Heart Assoc. 2020 Jan 21;9(2):e013754
pubmed: 31960736
J Cardiovasc Med (Hagerstown). 2018 Oct;19(10):546-553
pubmed: 30119096
J Clin Invest. 2000 Sep;106(5):R31-8
pubmed: 10974026
World J Crit Care Med. 2015 May 04;4(2):130-8
pubmed: 25938028
Eur J Heart Fail. 2019 Dec;21(12):1515-1525
pubmed: 31321851
Nat Med. 2020 Sep;26(9):1452-1458
pubmed: 32661390
Heart Fail Rev. 2014 Sep;19(5):575-84
pubmed: 23925386
N Engl J Med. 2003 Apr 24;348(17):1625-38
pubmed: 12711737
Eur Heart J. 2019 Dec 14;40(47):3859-3868c
pubmed: 31800034
J Cancer Res Clin Oncol. 2012 May;138(5):867-75
pubmed: 22311183
BMC Cardiovasc Disord. 2018 Oct 22;18(1):198
pubmed: 30348102
Cardiorenal Med. 2013 Oct;3(3):208-220
pubmed: 24454316
J Am Heart Assoc. 2014 Nov 25;3(6):e001493
pubmed: 25424575
BMJ. 2013 May 21;346:f2360
pubmed: 23694687
Int J Mol Sci. 2019 Mar 13;20(6):
pubmed: 30871282
Intern Med. 2002 Feb;41(2):79-83
pubmed: 11868612
Br J Cancer. 2015 Feb 3;112(3):580-93
pubmed: 25422909
Eur J Heart Fail. 2020 Feb;22(2):362-365
pubmed: 31944511
CA Cancer J Clin. 2010 Jul-Aug;60(4):207-21
pubmed: 20554718

Auteurs

Rudolf A de Boer (RA)

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Joseph Pierre Aboumsallem (JP)

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Valentina Bracun (V)

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Douglas Leedy (D)

Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA, USA.

Richard Cheng (R)

Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA, USA.

Sahishnu Patel (S)

Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

David Rayan (D)

Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

Svetlana Zaharova (S)

Cardio-Oncology Program, Division of Cardiovascular Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA.

Jennifer Rymer (J)

Duke University, Durham, NC, USA.

Jennifer M Kwan (JM)

Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA.

Joshua Levenson (J)

Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Claudio Ronco (C)

Department of Medicine, University of Padova, Padova, Italy.
International Renal Research Institute of Vicenza, Vicenza, Italy.
Department of Nephrology, San Bortolo Hospital, Vicenza, Italy.

Paaladinesh Thavendiranathan (P)

Division of Cardiology, Toronto General Hospital, Toronto, Canada.

Sherry-Ann Brown (SA)

Cardio-Oncology Program, Division of Cardiovascular Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA. shbrown@mcw.edu.

Classifications MeSH